<DOC>
	<DOCNO>NCT00203216</DOCNO>
	<brief_summary>The study drug levetiracetam FDA approve add-on medication treatment partial onset seizure adult epilepsy . The trade name Keppra® . This `` open-label '' trial , mean participate patient receive active study drug . The Jefferson Headache Center develop clinical study evaluate safety effectiveness levetiracetam prevent migraine headache , without aura ( visual disturbance ) . In addition , study site perform procedure call Transcranial Magnetic Stimulation ( TMS ) . This procedure measure brain activity think people migraine experience period cortical hyperexcitability over-activity brain . This information may help physicians future determine preventive medication work patient .</brief_summary>
	<brief_title>A Clinical Study Examining Safety Effectiveness New Medication ( Keppra® ) Prevention Migraine Headaches</brief_title>
	<detailed_description />
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Etiracetam</mesh_term>
	<criteria>Patient male female age 18 65 Patient IHS diagnosis migraine without aura least oneyear prior screen Patient experience 4 10 migraine headache per month past six month , least 48 hour separate attack Patient able differentiate migraine attack headache type , applicable Patient currently 4 week precede screen receive prophylactic treatment indication migraine Patients daily medication remain stable dose 4 week precede screen Patient use agrees use duration participation medically acceptable form contraception ( determined investigator ) , female childbearing potential Patient negative urine pregnancy test prior study entry , female childbearing potential Patient able understand comply study requirement Patient provide write informed consent prior screen procedure conduct Women pregnant lactating Patients onset migraine 50 year age Patients experience &gt; 15 headache day per month Patients previously treat currently treat levitiracetam Patients fail great 3 adequate trial antiepileptic drug prevention migraine . Patients , investigator opinion , history evidence medical psychiatric condition would expose increase risk significant adverse event would interfere assessment efficacy tolerability trial Patients abnormal ECG , investigator opinion , would expose increase risk adverse event interfere study drug and/or analysis efficacy/tolerability Patients take medication acute treatment great 10 day per month past three month . Patients allergic show hypersensitivity compound similar levetiracetam Patients history significant drug alcohol abuse within past year Patients suicidal ideation 3 month prior screen history attempt suicide Patients currently history significantly impair renal function Patients participate investigational drug trial 30 day prior screen visit Patients Beck Depression Inventory score &gt; 18 screen Patients &gt; 0 question number 9 Beck Depression Inventory ( Suicidal Thoughts Wishes question ) Patients defibrillator pacemaker , implanted medication pump , metal plate skull , metal object inside eye skull ( e.g . shrapnel wound ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2011</verification_date>
</DOC>